标题
The clinical application of fruquintinib on colorectal cancer
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 12, Issue 8, Pages 713-721
出版商
Informa UK Limited
发表日期
2019-06-09
DOI
10.1080/17512433.2019.1630272
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC)
- (2018) Feng Tong et al. Bosnian Journal of Basic Medical Sciences
- Advances in CRC Prevention: Screening and Surveillance
- (2018) Evelien Dekker et al. GASTROENTEROLOGY
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung Cancer
- (2018) Shun Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
- (2018) Manuela Porru et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- (2018) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Fruquintinib for previously treated metastatic colorectal cancer
- (2018) Talha Khan Burki LANCET ONCOLOGY
- Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production
- (2018) Azin Jafari et al. Oncotarget
- LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions
- (2018) Cristina Barbagallo et al. Molecular Therapy-Nucleic Acids
- γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer
- (2018) Yunben Yang et al. Frontiers in Immunology
- Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014)
- (2018) Benjamin Ansa et al. Journal of Clinical Medicine
- Fruquintinib: First Global Approval
- (2018) Matt Shirley DRUGS
- EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers
- (2018) Mariangela De Robertis et al. Molecular Cancer
- Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
- (2017) Sebastian Stintzing et al. EUROPEAN JOURNAL OF CANCER
- No back seat for a progression event—K-RAS as a therapeutic target in CRC
- (2017) Emily J. Poulin et al. GENES & DEVELOPMENT
- Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
- (2017) Yuji Miyamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
- (2017) Rui-Hua Xu et al. Journal of Hematology & Oncology
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Colorectal cancer drugs market
- (2017) Sorcha Cassidy et al. NATURE REVIEWS DRUG DISCOVERY
- Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
- (2017) Guihua Wang et al. Cell Death & Disease
- RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
- (2017) Xiao-Yan Wang et al. Scientific Reports
- Non–Small Cell Lung Cancer
- (2017) Journal of the National Comprehensive Cancer Network
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer
- (2017) Robin K. Kelley et al. Journal of the National Comprehensive Cancer Network
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Gut Microbiota, Inflammation, and Colorectal Cancer
- (2016) Caitlin A. Brennan et al. Annual Review of Microbiology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors
- (2016) Junning Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study
- (2016) Takayuki Yoshino et al. Clinical Colorectal Cancer
- Novel anti-angiogenic therapeutic strategies in colorectal cancer
- (2016) M. Tampellini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- The non-small-cell lung cancer drug market
- (2016) Khurram Nawaz et al. NATURE REVIEWS DRUG DISCOVERY
- Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature
- (2016) Sheng Guo et al. Oncotarget
- MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals
- (2016) Hou-Qun Ying et al. Oncotarget
- Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
- (2016) Suk-young Lee et al. Biomed Research International
- Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy
- (2015) Elena De Mattia et al. DRUG RESISTANCE UPDATES
- Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
- (2015) Joan Minguet et al. INTERNATIONAL JOURNAL OF CANCER
- A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer
- (2015) Xiao-Fen Li et al. MEDICINE
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- KRAS polymorphisms are associated with survival of CRC in Chinese population
- (2015) Qiong Dai et al. TUMOR BIOLOGY
- Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole–imidazole polyamide conjugate
- (2015) Kiriko Hiraoka et al. Nature Communications
- Developments in Screening Tests and Strategies for Colorectal Cancer
- (2015) Justin L. Sovich et al. Biomed Research International
- The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
- (2014) P W Voorneveld et al. BRITISH JOURNAL OF CANCER
- Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy
- (2014) Qiaoling Sun et al. CANCER BIOLOGY & THERAPY
- Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
- (2014) Yi Gu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammation and colorectal cancer, when microbiota-host mutualism breaks
- (2014) Marco Candela WORLD JOURNAL OF GASTROENTEROLOGY
- Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum
- (2014) Brigitte Buscher et al. Bioanalysis
- Host–microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer
- (2013) Shirin Moossavi et al. Expert Review of Clinical Immunology
- Plasma protein binding: From discovery to development
- (2013) Tonika Bohnert et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
- (2013) Timothy J. Price et al. Cancer Medicine
- Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
- (2012) Paolo Garagnani et al. CURRENT PHARMACEUTICAL DESIGN
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Colorectal cancer—driven by inflammation and gut bacteria?
- (2012) Katrina Ray Nature Reviews Gastroenterology & Hepatology
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- (2012) T. Maurer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Oncology Market Research Provides a Feasible Index for Standardization of Colorectal Cancer Chemotherapy
- (2011) Y. Inoue et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
- (2011) Shankar Balasubramanian et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma Protein Binding in Drug Discovery and Development
- (2010) Monique Howard et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
- (2010) Thomas Winder et al. GASTROENTEROLOGY
- Advances in the Treatment of Metastatic Colorectal Cancer
- (2009) Carla Kurkjian et al. AMERICAN JOURNAL OF THERAPEUTICS
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
- (2009) Fatima Haggar et al. Clinics in Colon and Rectal Surgery
- Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point
- (2008) N. Arber CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now